TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Study TRX109011/TRX109013, A Randomized, Double-blind, Double-dummy, Placebo-controlled,
Crossover Study to Evaluate the Efficacy of TREXIMET® (Sumatriptan + Naproxen Sodium) versus
Butalbital-containing Combination Medications (BCM) for the Acute Treatment of Migraine when
administered during the Moderate-Severe Pain Phase of the Migraine (Studies 1 and 2 of 2)